Provided by Tiger Fintech (Singapore) Pte. Ltd.

Estrella Immunopharma

0.9200
-0.1000-9.80%
Post-market: 0.92000.00000.00%17:18 EDT
Volume:236.47K
Turnover:225.42K
Market Cap:33.28M
PE:-3.74
High:1.11
Open:1.00
Low:0.8008
Close:1.02
Loading ...

Estrella Immunopharma Is Maintained at Buy by D. Boral Capital

Dow Jones
·
22 Feb

Estrella Immunopharma Completes First Dose Group in Non-Hodgkin Lymphoma Study

MT Newswires Live
·
22 Feb

BRIEF-Estrella Immunopharma Completes First Dose Cohort In Starlight-1 Trial And Receives Approval To Initiate Higher Dose Cohort

Reuters
·
21 Feb

Estrella Immunopharma completes first dose cohort in STARLIGHT trial

TIPRANKS
·
21 Feb

Estrella Immunopharma Completes First Dose Cohort in Starlight-1 Trial and Receives Approval to Initiate Higher Dose Cohort

THOMSON REUTERS
·
21 Feb

Estrella Immunopharma Completes First Dose Cohort in STARLIGHT-1 Trial and Receives Approval to Initiate Higher Dose Cohort

Business Wire
·
21 Feb

Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW) Receives Buy Rating with a 12-Month Price Target of $16.00 from D. Boral Capital

Business Wire
·
20 Feb

Estrella Immunopharma Initiated at Buy by D. Boral Capital

Dow Jones
·
18 Feb

Estrella Immunopharma initiated with a Buy at D. Boral Capital

TIPRANKS
·
18 Feb

BRIEF-Estrella Immunopharma Inc - Regains Compliance With Nasdaq Minimum Bid Price Requirement

Reuters
·
17 Dec 2024

Estrella Immunopharma Inc - Regains Compliance With Nasdaq Minimum Bid Price Requirement

THOMSON REUTERS
·
17 Dec 2024

Estrella Immunopharma files $100M common stock, warrants offering

TIPRANKS
·
13 Dec 2024

Estrella Immunopharma : May Offer, Sell up to $100 Mln of Common Stock, Warrants From Time to Time in One or More Transactions

THOMSON REUTERS
·
13 Dec 2024

BRIEF-Estrella Immunopharma Entered Amendment No. 2 To Common Stock Purchase Agreement Dated April 20, 2023

Reuters
·
06 Dec 2024

Estrella Immunopharma-Pursuant to Amendment, Co May Sell and Issue up to $50 Mln of Its Common Stock to White Lion From Time to Time

THOMSON REUTERS
·
06 Dec 2024